Survival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish community

Lupus

Volumn 22, Issue 11, 2013, Pages 1185-1191

  Voss, A ^a   Laustrup, H ^a   Hjelmborg, J ^b   Junker, P ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

antiphospholipid syndrome; cardiovascular disease; renal lupus; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; BELIMUMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID;

ADULT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; DENMARK; DISEASE COURSE; FEMALE; FOLLOW UP; HOSPITAL CARE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; REVIEW; STANDARDIZED MORTALITY RATIO; SURVIVAL RATE; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIPHOSPHOLIPID SYNDROME; CARDIOVASCULAR DISEASE; RENAL LUPUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; DENMARK; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84884560695     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313498796     Document Type: Review

References (30)

1. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002 ; 16: 847-858
2. Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: Mortality trends in systemic lupus erythematosus. Autoimmun Rev. 2004 ; 3: 423-453
3. Jacobsen S, Petersen J, Ullman S, et al. Mortality and causes of death in 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol. 1999 ; 28: 75-81
4. Mok CC, To CH, Ho LY, Yu KL. Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006. J Rheumatol. 2008 ; 35: 1978-1982
5. Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008 ; 35: 2152-2158
6. Gustafsson J, Simard JF, Gunnarsson I, et al. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study. Arthritis Res Ther. 2012 ; 14: R46 - R46
7. Alonso MD, Llorca J, Martinez-Vazquez F, et al. Systemic lupus erythematosus in northwestern Spain: A 20-year epidemiologic study. Medicine (Baltimore). 2011 ; 90: 350-358
8. Doria A, Iaccarino L, Ghirardello A, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med. 2006 ; 119: 700-706
9. Flower C, Hennis AJ, Hambleton IR, Nicholson GD, Liang MH. Systemic lupus erythematosus in an Afro-Caribbean population: Incidence, clinical manifestations and survival in the Barbados National Lupus Registry. Arthritis Care Res (Hoboken). 2012 ; 64: 1151-1158
10. Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum. 2011 ; 63: 1182-1189
11. Heller T, Ahmed M, Siddiqqi A, Wallrauch C, Bahlas S. Systemic lupus erythematosus in Saudi Arabia: Morbidity and mortality in a multiethnic population. Lupus. 2007 ; 16: 908-914
12. Kang KY, Kwok SK, Ju JH, et al. The causes of death in Korean patients with systemic lupus erythematosus over 11 years. Lupus. 2011 ; 20: 989-997
13. Pons-Estel GJ, Alarcón GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010 ; 39: 257-268
14. Sharma A, Shamanna SB, Kumar S, et al. Causes of mortality among inpatients with systemic lupus erythematosus in a tertiary care hospital in North India over a 10-year period. Lupus. 2013 ; 22: 216-222
15. Teh CL, Ling GR. Causes and predictors of mortality in hospitalized lupus patient in Sarawak General Hospital, Malaysia. Lupus. 2013 ; 22: 106-111
16. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976 ; 60: 221-225
17. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002 ; 61: 409-413
18. Nossent J, Cikes N, Kiss E, et al. Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: Relation to disease activity and damage accrual. Lupus. 2007 ; 16: 309-317
19. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: Clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol. 1998 ; 27: 98-105
20. Fries JF, Holman HR Major problems in internal medicine. Smith LH, ed. Philadelphia: WB Saunders Co ; 1975: 1-199.
21. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
22. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-369
23. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999 ; 94: 496-509
24. Laustrup H, Voss A, Green A, Junker P. SLE disease patterns in a Danish population-based lupus cohort: An 8-year prospective study. Lupus. 2010 ; 19: 239-246
25. Laustrup H, Voss A, Green A, Junker P. Occurrence of systemic lupus erythematosus in a Danish community: An 8-year prospective study. Scand J Rheumatol. 2009 ; 38: 128-132
26. Alarcón GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998 ; 41: 1173-1180
27. Lau CS, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: An overview. Lupus. 2006 ; 15: 715-719
28. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000 ; 27: 685-691
29. Mosca M, Tani C, Aringer M, et al. EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies. Ann Rheum Dis. 2009 ; 69: 1269-1274
30. Bertsias G, Ioannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008 ; 67: 195-205